Tamer Abdelhak, MD - Medicare Neurology in Ypsilanti, MI

Tamer Abdelhak, MD is a medicare enrolled "Psychiatry & Neurology - Neurology" physician in Ypsilanti, Michigan. He graduated from medical school in 1998 and has 26 years of diverse experience with area of expertise as Neurology. He is a member of the group practice Iha Health Services Corporation and his current practice location is Trinity Health Iha Medical Group Neurology, 5333 Mcauley Drive, Ypsilanti, Michigan. You can reach out to his office (for appointments etc.) via phone at (734) 712-1400.

Tamer Abdelhak is licensed to practice in Michigan (license number 4301090561) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1326100660.

Contact Information

Tamer Abdelhak, MD
Trinity Health Iha Medical Group Neurology, 5333 Mcauley Drive,
Ypsilanti, MI 48197-3412
(734) 712-1400
(734) 623-2857



Physician's Profile

Full NameTamer Abdelhak
GenderMale
SpecialityNeurology
Experience26 Years
LocationTrinity Health Iha Medical Group Neurology, Ypsilanti, Michigan
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Tamer Abdelhak graduated from medical school in 1998
  NPI Data:
  • NPI Number: 1326100660
  • Provider Enumeration Date: 12/14/2006
  • Last Update Date: 09/11/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 8022019504
  • Enrollment ID: I20070824000070

Medical Identifiers

Medical identifiers for Tamer Abdelhak such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1326100660NPI-NPPES
036136691MedicaidIL

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084A2900XPsychiatry & Neurology - Neurocritical Care 4301090561 (Michigan)Secondary
2084N0400XPsychiatry & Neurology - Neurology 25MA10779900 (New Jersey)Secondary
2084N0400XPsychiatry & Neurology - Neurology 72703-20 (Wisconsin)Secondary
2084N0400XPsychiatry & Neurology - Neurology D64711 (Maryland)Secondary
2084N0400XPsychiatry & Neurology - Neurology 036136691 (Illinois)Secondary
2084N0400XPsychiatry & Neurology - Neurology 302109 (New York)Secondary
2084V0102XPsychiatry & Neurology - Vascular Neurology 036-136691 (Illinois)Secondary
2084N0400XPsychiatry & Neurology - Neurology 4301090561 (Michigan)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
St Joseph Mercy HospitalAnn arbor, MIHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Iha Health Services Corporation2466351440911

News Archive

Scientist decodes the language of memory cells

When an infection attacks, the body's immune system sounds the alert, kills the invading germs and remembers the pathogen to protect against contracting the same type of infection again.

IntegenX to accelerate commercialization of human DNA identification system with SV acquisition

IntegenX Inc., a privately held company that is a leader in the emerging field of rapid human DNA identification, today announced that it has acquired SV Corp, a wholly owned subsidiary of GE Healthcare Bio-Sciences. IntegenX will leverage SV Corp's products and intellectual property assets to expand its consumables offering and to accelerate the commercialization of its RapidHIT 200 Human DNA Identification System.

Australian researchers awarded funding for new HIV vaccines

Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.

Sanofi-aventis completes exchange offer for all shares of Genzyme common stock

Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.

JAX professor receives HFSP grant for 3D genome studies of memory, learning and epilepsy

Jackson Laboratory Professor Yijun Ruan, Ph.D., a leader in the study of the three-dimensional organization of the human genome, has received a three-year grant totaling $1,050,000 from the international Human Frontier Science Program to explore the fundamental mechanics involved in memory and learning as well as epilepsy.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Tamer Abdelhak allows following entities to bill medicare on his behalf.
Entity NameHenry Ford Health System
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1134144801
PECOS PAC ID: 0547178311
Enrollment ID: O20031105000139

News Archive

Scientist decodes the language of memory cells

When an infection attacks, the body's immune system sounds the alert, kills the invading germs and remembers the pathogen to protect against contracting the same type of infection again.

IntegenX to accelerate commercialization of human DNA identification system with SV acquisition

IntegenX Inc., a privately held company that is a leader in the emerging field of rapid human DNA identification, today announced that it has acquired SV Corp, a wholly owned subsidiary of GE Healthcare Bio-Sciences. IntegenX will leverage SV Corp's products and intellectual property assets to expand its consumables offering and to accelerate the commercialization of its RapidHIT 200 Human DNA Identification System.

Australian researchers awarded funding for new HIV vaccines

Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.

Sanofi-aventis completes exchange offer for all shares of Genzyme common stock

Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.

JAX professor receives HFSP grant for 3D genome studies of memory, learning and epilepsy

Jackson Laboratory Professor Yijun Ruan, Ph.D., a leader in the study of the three-dimensional organization of the human genome, has received a three-year grant totaling $1,050,000 from the international Human Frontier Science Program to explore the fundamental mechanics involved in memory and learning as well as epilepsy.

Read more Medical News

› Verified 5 days ago

Entity NameCovenant Medical Center Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1972590412
PECOS PAC ID: 2769387778
Enrollment ID: O20031209000107

News Archive

Scientist decodes the language of memory cells

When an infection attacks, the body's immune system sounds the alert, kills the invading germs and remembers the pathogen to protect against contracting the same type of infection again.

IntegenX to accelerate commercialization of human DNA identification system with SV acquisition

IntegenX Inc., a privately held company that is a leader in the emerging field of rapid human DNA identification, today announced that it has acquired SV Corp, a wholly owned subsidiary of GE Healthcare Bio-Sciences. IntegenX will leverage SV Corp's products and intellectual property assets to expand its consumables offering and to accelerate the commercialization of its RapidHIT 200 Human DNA Identification System.

Australian researchers awarded funding for new HIV vaccines

Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.

Sanofi-aventis completes exchange offer for all shares of Genzyme common stock

Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.

JAX professor receives HFSP grant for 3D genome studies of memory, learning and epilepsy

Jackson Laboratory Professor Yijun Ruan, Ph.D., a leader in the study of the three-dimensional organization of the human genome, has received a three-year grant totaling $1,050,000 from the international Human Frontier Science Program to explore the fundamental mechanics involved in memory and learning as well as epilepsy.

Read more Medical News

› Verified 5 days ago

Entity NameIha Health Services Corporation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1457408965
PECOS PAC ID: 2466351440
Enrollment ID: O20040108000355

News Archive

Scientist decodes the language of memory cells

When an infection attacks, the body's immune system sounds the alert, kills the invading germs and remembers the pathogen to protect against contracting the same type of infection again.

IntegenX to accelerate commercialization of human DNA identification system with SV acquisition

IntegenX Inc., a privately held company that is a leader in the emerging field of rapid human DNA identification, today announced that it has acquired SV Corp, a wholly owned subsidiary of GE Healthcare Bio-Sciences. IntegenX will leverage SV Corp's products and intellectual property assets to expand its consumables offering and to accelerate the commercialization of its RapidHIT 200 Human DNA Identification System.

Australian researchers awarded funding for new HIV vaccines

Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.

Sanofi-aventis completes exchange offer for all shares of Genzyme common stock

Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.

JAX professor receives HFSP grant for 3D genome studies of memory, learning and epilepsy

Jackson Laboratory Professor Yijun Ruan, Ph.D., a leader in the study of the three-dimensional organization of the human genome, has received a three-year grant totaling $1,050,000 from the international Human Frontier Science Program to explore the fundamental mechanics involved in memory and learning as well as epilepsy.

Read more Medical News

› Verified 5 days ago

Entity NameMetropolitan Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1811937519
PECOS PAC ID: 5597651836
Enrollment ID: O20040507000012

News Archive

Scientist decodes the language of memory cells

When an infection attacks, the body's immune system sounds the alert, kills the invading germs and remembers the pathogen to protect against contracting the same type of infection again.

IntegenX to accelerate commercialization of human DNA identification system with SV acquisition

IntegenX Inc., a privately held company that is a leader in the emerging field of rapid human DNA identification, today announced that it has acquired SV Corp, a wholly owned subsidiary of GE Healthcare Bio-Sciences. IntegenX will leverage SV Corp's products and intellectual property assets to expand its consumables offering and to accelerate the commercialization of its RapidHIT 200 Human DNA Identification System.

Australian researchers awarded funding for new HIV vaccines

Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.

Sanofi-aventis completes exchange offer for all shares of Genzyme common stock

Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.

JAX professor receives HFSP grant for 3D genome studies of memory, learning and epilepsy

Jackson Laboratory Professor Yijun Ruan, Ph.D., a leader in the study of the three-dimensional organization of the human genome, has received a three-year grant totaling $1,050,000 from the international Human Frontier Science Program to explore the fundamental mechanics involved in memory and learning as well as epilepsy.

Read more Medical News

› Verified 5 days ago

Entity NameSt Josephs Hospital Of The Hospital Sisters Of The Third Order Of St F
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1164429908
PECOS PAC ID: 3870488596
Enrollment ID: O20220524001106

News Archive

Scientist decodes the language of memory cells

When an infection attacks, the body's immune system sounds the alert, kills the invading germs and remembers the pathogen to protect against contracting the same type of infection again.

IntegenX to accelerate commercialization of human DNA identification system with SV acquisition

IntegenX Inc., a privately held company that is a leader in the emerging field of rapid human DNA identification, today announced that it has acquired SV Corp, a wholly owned subsidiary of GE Healthcare Bio-Sciences. IntegenX will leverage SV Corp's products and intellectual property assets to expand its consumables offering and to accelerate the commercialization of its RapidHIT 200 Human DNA Identification System.

Australian researchers awarded funding for new HIV vaccines

Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.

Sanofi-aventis completes exchange offer for all shares of Genzyme common stock

Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.

JAX professor receives HFSP grant for 3D genome studies of memory, learning and epilepsy

Jackson Laboratory Professor Yijun Ruan, Ph.D., a leader in the study of the three-dimensional organization of the human genome, has received a three-year grant totaling $1,050,000 from the international Human Frontier Science Program to explore the fundamental mechanics involved in memory and learning as well as epilepsy.

Read more Medical News

› Verified 5 days ago

Entity NameSt Mary's Hospital Medical Center Of Green Bay Inc-hospital Sisters
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1649246877
PECOS PAC ID: 7719871268
Enrollment ID: O20220607000369

News Archive

Scientist decodes the language of memory cells

When an infection attacks, the body's immune system sounds the alert, kills the invading germs and remembers the pathogen to protect against contracting the same type of infection again.

IntegenX to accelerate commercialization of human DNA identification system with SV acquisition

IntegenX Inc., a privately held company that is a leader in the emerging field of rapid human DNA identification, today announced that it has acquired SV Corp, a wholly owned subsidiary of GE Healthcare Bio-Sciences. IntegenX will leverage SV Corp's products and intellectual property assets to expand its consumables offering and to accelerate the commercialization of its RapidHIT 200 Human DNA Identification System.

Australian researchers awarded funding for new HIV vaccines

Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.

Sanofi-aventis completes exchange offer for all shares of Genzyme common stock

Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.

JAX professor receives HFSP grant for 3D genome studies of memory, learning and epilepsy

Jackson Laboratory Professor Yijun Ruan, Ph.D., a leader in the study of the three-dimensional organization of the human genome, has received a three-year grant totaling $1,050,000 from the international Human Frontier Science Program to explore the fundamental mechanics involved in memory and learning as well as epilepsy.

Read more Medical News

› Verified 5 days ago

Entity NameSt Vincent Hospital-hospital Sisters-third Order Of St Francis
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1689694911
PECOS PAC ID: 5799694675
Enrollment ID: O20220607000831

News Archive

Scientist decodes the language of memory cells

When an infection attacks, the body's immune system sounds the alert, kills the invading germs and remembers the pathogen to protect against contracting the same type of infection again.

IntegenX to accelerate commercialization of human DNA identification system with SV acquisition

IntegenX Inc., a privately held company that is a leader in the emerging field of rapid human DNA identification, today announced that it has acquired SV Corp, a wholly owned subsidiary of GE Healthcare Bio-Sciences. IntegenX will leverage SV Corp's products and intellectual property assets to expand its consumables offering and to accelerate the commercialization of its RapidHIT 200 Human DNA Identification System.

Australian researchers awarded funding for new HIV vaccines

Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.

Sanofi-aventis completes exchange offer for all shares of Genzyme common stock

Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.

JAX professor receives HFSP grant for 3D genome studies of memory, learning and epilepsy

Jackson Laboratory Professor Yijun Ruan, Ph.D., a leader in the study of the three-dimensional organization of the human genome, has received a three-year grant totaling $1,050,000 from the international Human Frontier Science Program to explore the fundamental mechanics involved in memory and learning as well as epilepsy.

Read more Medical News

› Verified 5 days ago

Entity NameSt. Nicholas Hospital-sisters Of The Third Order Of St Francis
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1447737762
PECOS PAC ID: 8325931652
Enrollment ID: O20220705000162

News Archive

Scientist decodes the language of memory cells

When an infection attacks, the body's immune system sounds the alert, kills the invading germs and remembers the pathogen to protect against contracting the same type of infection again.

IntegenX to accelerate commercialization of human DNA identification system with SV acquisition

IntegenX Inc., a privately held company that is a leader in the emerging field of rapid human DNA identification, today announced that it has acquired SV Corp, a wholly owned subsidiary of GE Healthcare Bio-Sciences. IntegenX will leverage SV Corp's products and intellectual property assets to expand its consumables offering and to accelerate the commercialization of its RapidHIT 200 Human DNA Identification System.

Australian researchers awarded funding for new HIV vaccines

Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.

Sanofi-aventis completes exchange offer for all shares of Genzyme common stock

Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.

JAX professor receives HFSP grant for 3D genome studies of memory, learning and epilepsy

Jackson Laboratory Professor Yijun Ruan, Ph.D., a leader in the study of the three-dimensional organization of the human genome, has received a three-year grant totaling $1,050,000 from the international Human Frontier Science Program to explore the fundamental mechanics involved in memory and learning as well as epilepsy.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Tamer Abdelhak is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Tamer Abdelhak, MD
24 Frank Lloyd Wright Drive, Suite J2000,
Ann Arbor, MI 48105

Ph: (518) 262-5226
Tamer Abdelhak, MD
Trinity Health Iha Medical Group Neurology, 5333 Mcauley Drive,
Ypsilanti, MI 48197-3412

Ph: (734) 712-1400

News Archive

Scientist decodes the language of memory cells

When an infection attacks, the body's immune system sounds the alert, kills the invading germs and remembers the pathogen to protect against contracting the same type of infection again.

IntegenX to accelerate commercialization of human DNA identification system with SV acquisition

IntegenX Inc., a privately held company that is a leader in the emerging field of rapid human DNA identification, today announced that it has acquired SV Corp, a wholly owned subsidiary of GE Healthcare Bio-Sciences. IntegenX will leverage SV Corp's products and intellectual property assets to expand its consumables offering and to accelerate the commercialization of its RapidHIT 200 Human DNA Identification System.

Australian researchers awarded funding for new HIV vaccines

Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.

Sanofi-aventis completes exchange offer for all shares of Genzyme common stock

Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.

JAX professor receives HFSP grant for 3D genome studies of memory, learning and epilepsy

Jackson Laboratory Professor Yijun Ruan, Ph.D., a leader in the study of the three-dimensional organization of the human genome, has received a three-year grant totaling $1,050,000 from the international Human Frontier Science Program to explore the fundamental mechanics involved in memory and learning as well as epilepsy.

Read more News

› Verified 5 days ago


Psychiatry & Neurology Doctors in Ypsilanti, MI

Theron Leroy Dobson, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 5333 Mcauley Dr, Ste 6109, Ypsilanti, MI 48197
Phone: 734-712-1400    Fax: 734-712-1670
Dr. Emily Lauren Westbury, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 5333 Mcauley Dr, Suite 6109, Ypsilanti, MI 48197
Phone: 734-712-1400    Fax: 734-623-2857
Srijan Adhikari, MD
Psychiatry & Neurology
Medicare: Medicare Enrolled
Practice Location: Trinity Health Iha Medical Group Neurology, 5333 Mcauley Drive, Ypsilanti, MI 48197
Phone: 734-712-1400    Fax: 734-623-2857
Patricia Anne Santy, MD
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 555 Towner St, Ypsilanti, MI 48198
Phone: 734-544-3000    Fax: 734-544-6732
Montgomery Clayton Brower, M.D.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 555 Towner St, Ypsilanti, MI 48198
Phone: 734-544-3050    Fax: 734-544-6732
Dr. Kirtida A Patel, M.D.
Psychiatry & Neurology
Medicare: Not Enrolled in Medicare
Practice Location: 3201 Bemis Road, Huron Valley Complex-men's, Ypsilanti, MI 48197
Phone: 734-572-9942    
Rachel Leigh Kraft, D.O.
Psychiatry & Neurology
Medicare: Accepting Medicare Assignments
Practice Location: 5333 Mcauley Dr, Ste 6109, Ypsilanti, MI 48197
Phone: 734-178-1400    Fax: 734-623-2857

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.